Therapy for hepatitis C--the costs of success

N Engl J Med. 2014 Apr 17;370(16):1552-3. doi: 10.1056/NEJMe1401508. Epub 2014 Apr 11.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Female
  • Fluorenes / therapeutic use*
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Male
  • Sofosbuvir
  • Uridine Monophosphate / analogs & derivatives*
  • Uridine Monophosphate / therapeutic use

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • ledipasvir
  • Uridine Monophosphate
  • Sofosbuvir